Startup | August 25, 2021
Regimen launches world’s first personalised digital therapy for ED
The company recently raised US $ 2.25 million seed round and the app was CE-Certified as a medical device in Europe
The company recently raised US $ 2.25 million seed round and the app was CE-Certified as a medical device in Europe
The investment will establish drug product manufacturing capacity for clinical trial and commercial supply in China and offer customers combined drug substance and drug product manufacturing services
Goal of providing 12-month internship opportunities for qualified students
The agreement is to develop, manufacture and commercialise biosimilars for the global market.
The co-investment of CHF 4 million will result in capacity expansion and support the market introduction of the customer's lead compound
The aim is to give a fillip to R&D in the health sector to face the Covid-19 challenge
Viraleze was developed for application in the nasal cavity to help reduce exposure to respiratory viruses, including SARS-CoV-2. The product is registered for sale in Europe and India, and available online in certain markets
The module offers the first preclinical laboratory information system of its kind that is fully integrated into the digital pathology workflow and provides efficient pathological studies of whole slides
This year, the company plans to set up more than 200 labs and 3000 collection centres across the world and has ended FY 21 with a revenue of Rs 800 crores
The foundation has been working closely with the Kidwai Memorial Institute of Oncology on several projects since 2001
Subscribe To Our Newsletter & Stay Updated
